AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34128838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 34620035 — intervention group
Group type: EXPERIMENTAL
Intervention: My Guide smartphone application
Number of subjects: 78
Study 34620035 — intervention group
Group type: COMPARATOR
Intervention: My Health smartphone application (attention-control condition)
Number of subjects: 78
Study 32917672 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivationally informed antidoping intervention for coaches (workshops and supplementary information)
Number of subjects: 1049
Study 32917672 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivationally informed antidoping intervention for coaches
Number of subjects: 1049
Study 32917672 — intervention group
Group type: COMPARATOR
Intervention: Standard antidoping workshop (control group)
Number of subjects: 1049
Study 35019238 — intervention group
Group type: COMPARATOR
Intervention: Etavopivat (single oral dose)
Number of subjects: 90
Study 35019238 — intervention group
Group type: COMPARATOR
Intervention: Etavopivat (14 days of multiple ascending doses)
Number of subjects: 90
Study 35019238 — intervention group
Group type: COMPARATOR
Intervention: Etavopivat
Number of subjects: 90
Study 32888814 — intervention group
Group type: EXPERIMENTAL
Intervention: Video interpretation
Number of subjects: 0
Study 32888814 — intervention group
Group type: COMPARATOR
Intervention: Telephone interpretation
Number of subjects: 0
Study 36204960 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D printing removable dentures
Number of subjects: 80
Study 36204960 — intervention group
Group type: COMPARATOR
Intervention: Plaster casting removable dentures
Number of subjects: 80
Study 33766069 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding satisfaction measured by the Maternal Breastfeeding Evaluation Scale
Number of subjects: 493
Study 33766069 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding satisfaction
Number of subjects: 493
Study 33766069 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal educational level, parity, multiple birth, or maternal birth country other than Sweden
Number of subjects: 493
Study 32327255 — intervention group
Group type: EXPERIMENTAL
Intervention: Tube shunt surgery (350‐mm2 Baerveldt implant)
Number of subjects: 122
Study 32327255 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy with mitomycin C (MMC) (0.4 mg/ml for 4 minutes)
Number of subjects: 122
Study 35020797 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g cefazolin administered before incision
Number of subjects: 457
Study 35020797 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic prophylaxis
Number of subjects: 457
Study 33714508 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep dry needling technique + routine physical therapy
Number of subjects: 66
Study 33714508 — intervention group
Group type: EXPERIMENTAL
Intervention: Hong's dry needling technique + routine physiotherapy
Number of subjects: 66
Study 33714508 — intervention group
Group type: COMPARATOR
Intervention: Routine physical therapy
Number of subjects: 66
Study 32404076 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamification using a board game
Number of subjects: 94
Study 32404076 — intervention group
Group type: COMPARATOR
Intervention: Conventional lecture
Number of subjects: 94
Study 86073140 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal glucagon (1 mg) plus sodium glycocholate (15 mg)
Number of subjects: 0
Study 86073140 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous glucagon
Number of subjects: 0
Study 86073140 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular glucagon
Number of subjects: 0
Study 86073140 — intervention group
Group type: COMPARATOR
Intervention: Surfactant alone
Number of subjects: 0
Study 86073140 — intervention group
Group type: COMPARATOR
Intervention: Glucagon alone
Number of subjects: 0
Study 36257222 — intervention group
Group type: EXPERIMENTAL
Intervention: Magic recreation program (6 weeks)
Number of subjects: 12
Study 36257222 — intervention group
Group type: COMPARATOR
Intervention: Usual activities (control group)
Number of subjects: 12
Study 32852358 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescribed walking program
Number of subjects: 0
Study 32852358 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 33895682 — intervention group
Group type: EXPERIMENTAL
Intervention: Regorafenib
Number of subjects: 46
Study 33895682 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 34732357 — intervention group
Group type: EXPERIMENTAL
Intervention: Danhong injection (DHI)
Number of subjects: 160
Study 34732357 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 33827145 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted psychological interventions for depression delivered by trained health professionals alongside a supporter
Number of subjects: 27
Study 33827145 — intervention group
Group type: EXPERIMENTAL
Intervention: Supporters' involvement in therapy
Number of subjects: 27
Study 33827145 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular clinical supervision
Number of subjects: 27
Study 34980828 — intervention group
Group type: EXPERIMENTAL
Intervention: AH Plus
Number of subjects: 100
Study 34980828 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulp Canal Sealer
Number of subjects: 100
Study 34980828 — intervention group
Group type: EXPERIMENTAL
Intervention: NeoSEALER Flo
Number of subjects: 100
Study 34980828 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoSequence BC
Number of subjects: 100
Study 34980828 — intervention group
Group type: EXPERIMENTAL
Intervention: Super‐Bond RC Sealer
Number of subjects: 100
Study 32135454 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated rapid eye movement sleep behavior disorder (iRBD) patients
Number of subjects: 37
Study 32135454 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 37
Study 32135454 — intervention group
Group type: EXPERIMENTAL
Intervention: iRBD patients
Number of subjects: 37
Study 35352600 — intervention group
Group type: EXPERIMENTAL
Intervention: CBIA (app-based cognitive-behavioral intervention)
Number of subjects: 87
Study 35352600 — intervention group
Group type: EXPERIMENTAL
Intervention: CBIA + CC (app-based cognitive-behavioral intervention supplemented with telephone conference calls)
Number of subjects: 87
Study 35352600 — intervention group
Group type: COMPARATOR
Intervention: ACG (attention control group)
Number of subjects: 87
Study 32107160 — intervention group
Group type: EXPERIMENTAL
Intervention: Reiki intervention applied preoperatively, details on dosage and duration not available.
Number of subjects: 210
Study 32107160 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Reiki intervention).
Number of subjects: 210
Study 32721578 — intervention group
Group type: EXPERIMENTAL
Intervention: Current asthma education program + placement of two indoor air cleaners in the family's home
Number of subjects: 0
Study 32721578 — intervention group
Group type: COMPARATOR
Intervention: Current asthma education program
Number of subjects: 0
Study 35100970 — intervention group
Group type: EXPERIMENTAL
Intervention: High RV pacing burden (hRVP: ≥ 40%)
Number of subjects: 60
Study 35100970 — intervention group
Group type: COMPARATOR
Intervention: Low RV pacing burden (lRVP < 40%)
Number of subjects: 60
Study 35100970 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (hRVP and lRVP)
Number of subjects: 60
Study 34036355 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc-biofortified wheat (10.9 mg zinc/d, 0.6 g total phytate/d)
Number of subjects: 36
Study 34036355 — intervention group
Group type: COMPARATOR
Intervention: Zinc supplementation (25 mg/d) in MP3
Number of subjects: 36
Study 35798633 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 40
Study 35798633 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 40
Study 33464703 — intervention group
Group type: EXPERIMENTAL
Intervention: EXE + DAPA
Number of subjects: 30
Study 33464703 — intervention group
Group type: COMPARATOR
Intervention: PLAC + DAPA
Number of subjects: 30
Study 36104135 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal surgical resection followed by chemoradiotherapy plus adjuvant chemotherapy for 6 months with neoadjuvant chemotherapy
Number of subjects: 0
Study 36104135 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal surgical resection followed by chemoradiotherapy plus adjuvant chemotherapy for 6 months with extended adjuvant chemotherapy until progression
Number of subjects: 0
Study 36104135 — intervention group
Group type: COMPARATOR
Intervention: Maximal surgical resection followed by chemoradiotherapy plus adjuvant chemotherapy for 6 months
Number of subjects: 0
Study 36104135 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 0
Study 36104135 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended adjuvant chemotherapy until progression
Number of subjects: 0
Study 32931545 — intervention group
Group type: EXPERIMENTAL
Intervention: Wuqinxi (WQX) exercise programme
Number of subjects: 68
Study 32931545 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 68
Study 34311119 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy for sleep disturbance and fatigue (CBT‐SF)
Number of subjects: 51
Study 34311119 — intervention group
Group type: COMPARATOR
Intervention: Health education (HE)
Number of subjects: 51
Study 35397352 — intervention group
Group type: EXPERIMENTAL
Intervention: Real TENS (frequency 100 Hz, pulse width 200 microseconds, voltage 2 mA)
Number of subjects: 100
Study 35397352 — intervention group
Group type: COMPARATOR
Intervention: Sham TENS
Number of subjects: 100
Study 35397352 — intervention group
Group type: EXPERIMENTAL
Intervention: Real TENS
Number of subjects: 100
Study 34058254 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative SRS
Number of subjects: 242
Study 34058254 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtotal resection (STR)
Number of subjects: 242
Study 32077404 — intervention group
Group type: EXPERIMENTAL
Intervention: BRA intervention
Number of subjects: 73
Study 32077404 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 73
Study 35418091 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (2 capsules/day for 6 weeks containing L.acidophilus, L.plantarum, L.fermentum, L.Gasseri, and fructo-oligo-saccharides)
Number of subjects: 60
Study 35418091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 35698099 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication Bridge™ intervention (dyadic intervention based in communication participation therapy models)
Number of subjects: 90
Study 35698099 — intervention group
Group type: COMPARATOR
Intervention: Control intervention (non-dyadic intervention based in impairment therapy models)
Number of subjects: 90
Study 34450120 — intervention group
Group type: EXPERIMENTAL
Intervention: Precision vestibular rehabilitation (VESTIB) for 30 minutes/day for 4 weeks
Number of subjects: 55
Study 34450120 — intervention group
Group type: COMPARATOR
Intervention: Behavioral management control (CONTROL) for 30 minutes/day for 4 weeks
Number of subjects: 55
Study 35704507 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-paced diaphragmatic breathing exercise
Number of subjects: 171
Study 34303862 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian two-stage adaptive design for MinED-based dosing-finding trials
Number of subjects: 0
Study 34303862 — intervention group
Group type: EXPERIMENTAL
Intervention: Random scenario generative algorithm for MinED
Number of subjects: 0
Study 34578873 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg DHA/day
Number of subjects: 543
Study 34578873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 543
Study 33362392 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative early enteral nutrition (EEN) + parenteral nutrition (PN)
Number of subjects: 60
Study 33362392 — intervention group
Group type: COMPARATOR
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 60
Study 33666898 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide overnight tray system
Number of subjects: 0
Study 33666898 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 36156443 — intervention group
Group type: EXPERIMENTAL
Intervention: Muvity telerehabilitation system
Number of subjects: 10
Study 36156443 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 10
Study 34704711 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mL normal saline
Number of subjects: 71
Study 34704711 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mL normal saline
Number of subjects: 71
Study 34704711 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL normal saline
Number of subjects: 71
Study 34704711 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline measurement)
Number of subjects: 71
Study 32660833 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg⋅day−1 astaxanthin for 7 days
Number of subjects: 12
Study 32660833 — intervention group
Group type: COMPARATOR
Intervention: Appearance-matched placebo for 7 days
Number of subjects: 12
Study 33098856 — intervention group
Group type: EXPERIMENTAL
Intervention: Berotralstat 110 mg
Number of subjects: 121
Study 33098856 — intervention group
Group type: EXPERIMENTAL
Intervention: Berotralstat 150 mg
Number of subjects: 121
Study 33098856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 32785021 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle5 supplement (M5) with home-based resistance exercise (HBRE)
Number of subjects: 32
Study 32785021 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA) with home-based resistance exercise (HBRE)
Number of subjects: 32
Study 35797029 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-based information and coaching/support program
Number of subjects: 102
Study 34825640 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation exercises (REs) of lower limbs and instructions of daily care (ID-C) for 12 weeks
Number of subjects: 0
Study 34825640 — intervention group
Group type: COMPARATOR
Intervention: Instructions of daily care (ID-C) only for 12 weeks
Number of subjects: 0
Study 32182310 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet + 7% 'Ziluolan' (F)
Number of subjects: 56
Study 32182310 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet + 5% 'Ziluolan' (E)
Number of subjects: 56
Study 32182310 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet + 7% 'Suzhouqing' (D)
Number of subjects: 56
Study 32182310 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet (B)
Number of subjects: 56
Study 32182310 — intervention group
Group type: COMPARATOR
Intervention: Normal diet (A)
Number of subjects: 56
Study 34759239 — intervention group
Group type: EXPERIMENTAL
Intervention: Pudendal nerve block with 5 mL bupivacaine 0.5% with adrenaline 1:200,000
Number of subjects: 80
Study 34759239 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving local wound infiltration
Number of subjects: 80
Study 34759239 — intervention group
Group type: EXPERIMENTAL
Intervention: Pudendal nerve block
Number of subjects: 80
Study 34759239 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study 33902667 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care cardiopulmonary ultrasound examination
Number of subjects: 211
Study 33902667 — intervention group
Group type: COMPARATOR
Intervention: Standard clinical examination alone
Number of subjects: 211
Study 36476152 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrate
Number of subjects: 20
Study 36476152 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 32674392 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-led total sanitation (CLTS) intervention
Number of subjects: 0
Study 32674392 — intervention group
Group type: COMPARATOR
Intervention: Existing local government program
Number of subjects: 0
Study 34915106 — intervention group
Group type: COMPARATOR
Intervention: 0 g protein water control (WC)
Number of subjects: 24
Study 34915106 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 g low-dose protein (LP)
Number of subjects: 24
Study 34915106 — intervention group
Group type: EXPERIMENTAL
Intervention: 50.0 g high-dose protein (HP)
Number of subjects: 24
Study 34915106 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-rising protein beverage
Number of subjects: 24
Study 34915106 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate models incorporating multiple biomarkers
Number of subjects: 24
Study 32064499 — intervention group
Group type: EXPERIMENTAL
Intervention: Temozolomide (TMZ)
Number of subjects: 369
Study 32064499 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy (RT)
Number of subjects: 369
Study 35346735 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity acute aerobic exercise for 20 minutes
Number of subjects: 160
Study 35346735 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity acute aerobic exercise for 20 minutes
Number of subjects: 160
Study 35346735 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity acute aerobic exercise for 20 minutes
Number of subjects: 160
Study 35346735 — intervention group
Group type: COMPARATOR
Intervention: Control group (watched a 20-minute documentary)
Number of subjects: 160
Study 34120448 — intervention group
Group type: EXPERIMENTAL
Intervention: GRS‐WHR324 (waist‐to‐hip ratio)
Number of subjects: 795
Study 34120448 — intervention group
Group type: EXPERIMENTAL
Intervention: GRS‐BMI565 (body mass index)
Number of subjects: 795
Study 34120448 — intervention group
Group type: EXPERIMENTAL
Intervention: GRS‐VAT208 (visceral adipose tissue)
Number of subjects: 795
Study 34120448 — intervention group
Group type: EXPERIMENTAL
Intervention: GRS‐BF81 (body fat)
Number of subjects: 795
Study 32589229 — intervention group
Group type: EXPERIMENTAL
Intervention: Active vitamin supplementation
Number of subjects: 3365
Study 32589229 — intervention group
Group type: EXPERIMENTAL
Intervention: Active garlic supplementation
Number of subjects: 3365
Study 32589229 — intervention group
Group type: COMPARATOR
Intervention: Placebo for vitamin supplementation
Number of subjects: 3365
Study 32589229 — intervention group
Group type: COMPARATOR
Intervention: Placebo for garlic supplementation
Number of subjects: 3365
Study 35565100 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean style dietary pattern with high intensity interval training (HIIT)
Number of subjects: 23
Study 35565100 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 23
Study 32726566 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% CHO MR solution
Number of subjects: 12
Study 32726566 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study 34579122 — intervention group
Group type: EXPERIMENTAL
Intervention: PPN with periOlimel N4‐E
Number of subjects: 156
Study 34579122 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluid therapy
Number of subjects: 156
Study 34579122 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk BC
Number of subjects: 156
Study 34319864 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted vest (20 lb for males, 14 lb for females) during running trials
Number of subjects: 20
Study 34319864 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted vest (20 lb for males, 14 lb for females) during walking trials at 10% gradient
Number of subjects: 20
Study 34319864 — intervention group
Group type: COMPARATOR
Intervention: No weighted vest during walking and running trials
Number of subjects: 20
Study 33711781 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate 3-monthly (PP3M)
Number of subjects: 159
Study 33711781 — intervention group
Group type: COMPARATOR
Intervention: Paliperidone palmitate 1-monthly (PP1M)
Number of subjects: 159
Study 32246728 — intervention group
Group type: EXPERIMENTAL
Intervention: Low ascending doses of oral NTX (NTX/BUP, n=50)
Number of subjects: 101
Study 32246728 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO-N/BUP, n=51)
Number of subjects: 101
Study 32246728 — intervention group
Group type: EXPERIMENTAL
Intervention: Low ascending doses of oral NTX (NTX/BUP)
Number of subjects: 101
Study 32246728 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO-N/BUP)
Number of subjects: 101
Study 35513899 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily fixed combination of bimatoprost 0.01%, brimonidine tartrate 0.15%, and timolol maleate 0.5%
Number of subjects: 30
Study 35513899 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily fixed combination of bimatoprost 0.01%, brimonidine tartrate 0.15%, and timolol maleate 0.5%
Number of subjects: 30
Study 34742270 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal mammary node irradiation (IMNI)
Number of subjects: 1800
Study 34742270 — intervention group
Group type: COMPARATOR
Intervention: No internal mammary node irradiation (IMNI)
Number of subjects: 1800
Study 34723897 — intervention group
Group type: EXPERIMENTAL
Intervention: Media-based educational materials
Number of subjects: 135
Study 34723897 — intervention group
Group type: COMPARATOR
Intervention: Print-based educational materials
Number of subjects: 135
Study 34723897 — intervention group
Group type: EXPERIMENTAL
Intervention: Both media and print-based educational materials
Number of subjects: 135
Study 32046415 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide acetate treatment
Number of subjects: 0
Study 32046415 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetrorelix treatment
Number of subjects: 0
Study 32046415 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study 32046415 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (comparison of leiomyoma to myometrium)
Number of subjects: 0
Study 32046415 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (immunohistochemical analysis)
Number of subjects: 0
Study 32046415 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (qRT-PCR results)
Number of subjects: 0
Study 33269876 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprint Interval Training (SIT)
Number of subjects: 52
Study 33269876 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Aerobic + Resistance Training (COMB)
Number of subjects: 52